Ginkgo Bioworks   and Boehringer Ingelheim Pharmaceuticals, Inc. have partnered to leverage Ginkgo’s natural product discovery capabilities to accelerate the discovery and development of novel therapeutic molecules to address diseases with high unmet patient needs that are out of reach of conventional drug discovery. The two companies will collaborate to mine Ginkgo’s metagenomic sequence database, which provides access to a vast reservoir of structurally novel bioactive molecules...